Trials / Completed
CompletedNCT02477033
Impact of Butyricicoccus Pullicaecorum in Healthy Subjects
A Placebo-controlled Cross-over Randomized Study to Investigate the Impact of Butyricicoccus Pullicaecorum in Healthy Human Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- KU Leuven · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
During this project the safety, tolerability and effect on gut microbiota of oral administration of Butyricicoccus pullicaecorum was investigated in healthy human volunteers by a placebo-controlled cross-over randomized study.
Detailed description
Intervention periods were 4 weeks, with daily intake of 1 capsule. Wash-out periods were 3 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Butyricicoccus pullicaecorum 25-3T | |
| OTHER | Maltodextrin |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2014-06-01
- Completion
- 2015-02-01
- First posted
- 2015-06-22
- Last updated
- 2015-06-22
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02477033. Inclusion in this directory is not an endorsement.